PhiFund Ventures

PhiFund Ventures operates as a venture capital firm focused on early-stage life sciences, creating and supporting companies poised to transform healthcare. It identifies promising academic intellectual property and nurtures nascent businesses. The firm's approach accelerates development, aiming to significantly advance medical diagnosis and treatment.

Established in 2021, PhiFund Ventures was co-founded by Patricia Tolete, Michael Jasulavic, and Dr. Orrin Devinsky. Tolete brings extensive clinical trial management and operations experience. Jasulavic contributes over 15 years in healthcare investment research. Dr. Devinsky, a distinguished neurologist, provides deep clinical development expertise, translating scientific breakthroughs into patient solutions.

PhiFund Ventures partners with early-stage life science companies and institutions holding academic intellectual property. The firm's mission is to drive substantial advancements in diagnosis and treatment, fundamentally transforming healthcare outcomes. Its vision connects groundbreaking scientific innovation with critical, unmet medical needs across the healthcare landscape.